These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34365978)

  • 1. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study.
    Ming J; Yu X; Xu X; Wang L; Ding C; Wang Z; Xie X; Li S; Yang W; Luo S; He Q; Du Y; Tian Z; Gao X; Ma K; Fang Y; Li C; Zhao J; Wang X; Ji Q
    Genome Med; 2021 Aug; 13(1):125. PubMed ID: 34365978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial.
    Ming J; Xu S; Liu C; Liu X; Jia A; Ji Q
    Trials; 2018 Jan; 19(1):72. PubMed ID: 29373989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).
    Zhang Y; Gu Y; Ren H; Wang S; Zhong H; Zhao X; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Kong P; Hou G; Gao M; Shi Z; Li X; Qiu Y; Zou Y; Yang H; Wang J; Xu G; Lai S; Li J; Ning G; Wang W
    Nat Commun; 2020 Oct; 11(1):5015. PubMed ID: 33024120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study.
    Wang S; Ren H; Zhong H; Zhao X; Li C; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Zou Y; Shi Z; Li X; Li T; Yang H; Lai S; Xu G; Li J; Zhang Y; Gu Y; Wang W
    Gut Microbes; 2022; 14(1):2003176. PubMed ID: 34923903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp.
    Ba Z; Lee Y; Meng H; Kris-Etherton PM; Rogers CJ; Lewis ZT; Mills DA; Furumoto EJ; Rolon ML; Fleming JA; Roberts RF
    mSphere; 2021 Aug; 6(4):e0008421. PubMed ID: 34232082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Combined Prebiotic Galacto-Oligosaccharides and
    Beteri B; Barone M; Turroni S; Brigidi P; Tzortzis G; Vulevic J; Sekulic K; Motei DE; Costabile A
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064648
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Merenstein D; Fraser CM; Roberts RF; Liu T; Grant-Beurmann S; Tan TP; Smith KH; Cronin T; Martin OA; Sanders ME; Lucan SC; Kane MA
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota mediated benefits of barley kernel products on metabolism, gut hormones, and inflammatory markers as affected by co-ingestion of commercially available probiotics: a randomized controlled study in healthy subjects.
    Nilsson A; Johansson-Boll E; Sandberg J; Björck I
    Clin Nutr ESPEN; 2016 Oct; 15():49-56. PubMed ID: 28531784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome.
    Liu A; Ma T; Xu N; Jin H; Zhao F; Kwok LY; Zhang H; Zhang S; Sun Z
    Microbiol Spectr; 2021 Oct; 9(2):e0085921. PubMed ID: 34612663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.
    Lai H; Li Y; He Y; Chen F; Mi B; Li J; Xie J; Ma G; Yang J; Xu K; Liao X; Yin Y; Liang J; Kong L; Wang X; Li Z; Shen Y; Dang S; Zhang L; Wu Q; Zeng L; Shi L; Zhang X; Tian T; Liu X
    Gut Microbes; 2023; 15(1):2197837. PubMed ID: 37078654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial.
    Panigrahi A; Mohanty S
    BMC Endocr Disord; 2023 Sep; 23(1):190. PubMed ID: 37679692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
    Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
    Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effect of Two Probiotics on the Preterms' Gut Microbiota.
    Moreno-Sanz B; Montes MT; Manzano S; Espinosa-Martos I; Cárdenas N; Esteban S; Cruz M; Jiménez E; de Pipaón MS
    J Pediatr Gastroenterol Nutr; 2022 Jun; 74(6):e153-e159. PubMed ID: 35221319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-masked placebo-controlled trial assessing effects of various doses of BTS 67,582, a novel insulinotropic agent, on fasting hyperglycemia in NIDDM patients.
    Skillman CA; Raskin P
    Diabetes Care; 1997 Apr; 20(4):591-6. PubMed ID: 9096985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial.
    Firouzi S; Majid HA; Ismail A; Kamaruddin NA; Barakatun-Nisak MY
    Eur J Nutr; 2017 Jun; 56(4):1535-1550. PubMed ID: 26988693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity.
    Nicolucci AC; Hume MP; Martínez I; Mayengbam S; Walter J; Reimer RA
    Gastroenterology; 2017 Sep; 153(3):711-722. PubMed ID: 28596023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.
    Merenstein DJ; Tan TP; Molokin A; Smith KH; Roberts RF; Shara NM; Mete M; Sanders ME; Solano-Aguilar G
    Gut Microbes; 2015; 6(1):66-77. PubMed ID: 25569274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.